19 June 2023 : Clinical Research
B-Type Natriuretic Peptide Can Distinguish Ischemic Stroke Subtypes Better than Other Cardiac Biomarkers
Ping Liang12ABCEF, Shuang Han12ADG, Yucen Jiang12B, Huikai Miao3BD*, Xiaowei Qi12ADGDOI: 10.12659/MSM.939829
Med Sci Monit 2023; 29:e939829
Table 2 Levels of BNP and other cardiac biomarkers in IS patients and healthy people.
| Groups | Median (inter-quartile range) | P | |||
|---|---|---|---|---|---|
| SVO | LAA | CE | Control | ||
| N | 67 | 104 | 52 | 75 | |
| BNP (pg/mL) | 40.00 (19.00–88.00) | 59.50 (26.25–105.75) | 125.00 (64.25–213.50) | 19.00 (12.00–32.00) | <0.001 |
| CK-MB (ng/mL) | 1.20 (0.80–1.60) | 1.40 (0.90–2.00) | 2.80 (1.60–5.08) | 1.20 (0.80–1.70) | <0.001 |
| cTnI (ng/mL) | 0.00 (0.00–0.01) | 0.01 (0.00–0.01) | 0.02 (0.01–0.08) | 0.00 (0.00–0.00) | <0.001 |
| MYO (ng/mL) | 19.30 (15.40–26.40) | 24.05 (17.73–32.40) | 84.65 (43.23–169.93) | 22.10 (19.10–27.10) | <0.001 |
| BNP – B-type natriuretic peptide; CK-MB – creatine kinase-MB; cTnI – cardiac troponin I; MYO – myoglobin; LAA – large-artery atherosclerosis; CE – cardioembolism; SVO – small-vessel occlusion. (It has been supplemented in the text and in the title upon first appearance). | |||||